ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/17 | 3,020 | 3,050 | 2,991 | 2,994 | -31 | -1% | 125,100 |
| 2022/05/16 | 3,110 | 3,130 | 2,994 | 3,025 | -50 | -1.6% | 145,800 |
| 2022/05/13 | 3,085 | 3,145 | 3,065 | 3,075 | -5 | -0.2% | 132,600 |
| 2022/05/12 | 3,135 | 3,135 | 3,070 | 3,080 | -75 | -2.4% | 88,200 |
| 2022/05/11 | 3,185 | 3,185 | 3,095 | 3,155 | -100 | -3.1% | 127,600 |
| 2022/05/10 | 3,220 | 3,275 | 3,210 | 3,255 | +35 | +1.1% | 100,200 |
| 2022/05/09 | 3,235 | 3,260 | 3,205 | 3,220 | -60 | -1.8% | 90,100 |
| 2022/05/06 | 3,225 | 3,290 | 3,205 | 3,280 | +50 | +1.5% | 68,500 |
| 2022/05/02 | 3,190 | 3,245 | 3,160 | 3,230 | +35 | +1.1% | 107,800 |
| 2022/04/28 | 3,040 | 3,200 | 3,040 | 3,195 | +150 | +4.9% | 139,000 |
| 2022/04/27 | 3,090 | 3,090 | 3,035 | 3,045 | -80 | -2.6% | 120,900 |
| 2022/04/26 | 3,115 | 3,125 | 3,100 | 3,125 | +15 | +0.5% | 98,100 |
| 2022/04/25 | 3,105 | 3,135 | 3,095 | 3,110 | -45 | -1.4% | 76,400 |
| 2022/04/22 | 3,160 | 3,175 | 3,135 | 3,155 | -10 | -0.3% | 65,700 |
| 2022/04/21 | 3,160 | 3,190 | 3,145 | 3,165 | -20 | -0.6% | 88,100 |
| 2022/04/20 | 3,185 | 3,215 | 3,155 | 3,185 | +35 | +1.1% | 58,200 |
| 2022/04/19 | 3,140 | 3,175 | 3,140 | 3,150 | ±0 | ±0% | 71,900 |
| 2022/04/18 | 3,180 | 3,195 | 3,130 | 3,150 | -75 | -2.3% | 67,400 |
| 2022/04/15 | 3,200 | 3,235 | 3,200 | 3,225 | -20 | -0.6% | 55,200 |
| 2022/04/14 | 3,230 | 3,270 | 3,230 | 3,245 | +15 | +0.5% | 38,200 |
| 2022/04/13 | 3,200 | 3,245 | 3,195 | 3,230 | +20 | +0.6% | 104,700 |
| 2022/04/12 | 3,265 | 3,270 | 3,200 | 3,210 | -80 | -2.4% | 83,300 |
| 2022/04/11 | 3,255 | 3,305 | 3,255 | 3,290 | +30 | +0.9% | 69,900 |
| 2022/04/08 | 3,265 | 3,275 | 3,230 | 3,260 | +40 | +1.2% | 115,500 |
| 2022/04/07 | 3,160 | 3,230 | 3,155 | 3,220 | ±0 | ±0% | 105,900 |
| 2022/04/06 | 3,235 | 3,270 | 3,175 | 3,220 | -30 | -0.9% | 194,800 |
| 2022/04/05 | 3,270 | 3,280 | 3,235 | 3,250 | -10 | -0.3% | 72,800 |
| 2022/04/04 | 3,250 | 3,275 | 3,205 | 3,260 | +25 | +0.8% | 80,500 |
| 2022/04/01 | 3,190 | 3,255 | 3,150 | 3,235 | +35 | +1.1% | 114,800 |
| 2022/03/31 | 3,275 | 3,290 | 3,195 | 3,200 | -120 | -3.6% | 175,100 |
| 2022/03/30 | 3,390 | 3,415 | 3,270 | 3,320 | -95 | -2.8% | 149,000 |
| 2022/03/29 | 3,370 | 3,415 | 3,365 | 3,415 | +40 | +1.2% | 113,700 |
| 2022/03/28 | 3,425 | 3,425 | 3,370 | 3,375 | -50 | -1.5% | 54,500 |
| 2022/03/25 | 3,415 | 3,430 | 3,385 | 3,425 | +55 | +1.6% | 92,500 |
| 2022/03/24 | 3,390 | 3,415 | 3,330 | 3,370 | -30 | -0.9% | 103,400 |
| 2022/03/23 | 3,330 | 3,430 | 3,310 | 3,400 | +110 | +3.3% | 140,800 |
| 2022/03/22 | 3,350 | 3,350 | 3,280 | 3,290 | -60 | -1.8% | 129,000 |
| 2022/03/18 | 3,385 | 3,405 | 3,335 | 3,350 | -35 | -1% | 118,000 |
| 2022/03/17 | 3,440 | 3,445 | 3,360 | 3,385 | -25 | -0.7% | 122,800 |
| 2022/03/16 | 3,435 | 3,495 | 3,390 | 3,410 | ±0 | ±0% | 144,700 |
| 2022/03/15 | 3,360 | 3,430 | 3,360 | 3,410 | +55 | +1.6% | 113,300 |
| 2022/03/14 | 3,335 | 3,395 | 3,315 | 3,355 | +35 | +1.1% | 95,900 |
| 2022/03/11 | 3,295 | 3,355 | 3,285 | 3,320 | -10 | -0.3% | 154,400 |
| 2022/03/10 | 3,285 | 3,345 | 3,260 | 3,330 | +155 | +4.9% | 128,200 |
| 2022/03/09 | 3,165 | 3,190 | 3,110 | 3,175 | -25 | -0.8% | 198,700 |
| 2022/03/08 | 3,165 | 3,220 | 3,150 | 3,200 | +25 | +0.8% | 210,100 |
| 2022/03/07 | 3,160 | 3,200 | 3,130 | 3,175 | -30 | -0.9% | 103,700 |
| 2022/03/04 | 3,235 | 3,240 | 3,190 | 3,205 | -5 | -0.2% | 105,000 |
| 2022/03/03 | 3,175 | 3,235 | 3,160 | 3,210 | +75 | +2.4% | 85,100 |
| 2022/03/02 | 3,175 | 3,200 | 3,130 | 3,135 | -55 | -1.7% | 89,200 |
751～
800
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
